Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The RNA-directed RNA polymerase L (L protein) of the Zaire ebolavirus is a massive, multifunctional enzyme that serves as the catalytic core of the viral replication complex (UniProt P35251). It is responsible for the transcription of viral genes into messenger RNAs (mRNAs) and the replication of the negative-sense genomic RNA (Wikipedia). The L protein also facilitates essential post-transcriptional modifications, including 5' capping and 3' polyadenylation of viral transcripts, which are necessary for translation by the host cell machinery (UniProt). Because it is vital for the viral life cycle and lacks a direct human counterpart, it is a high-priority target for antiviral drugs (Nature, 2016). Therapeutic approaches include small-molecule inhibitors like remdesivir, which act as chain terminators during RNA synthesis, and RNA interference (RNAi) technologies like TKM-Ebola that specifically target the L polymerase mRNA to block protein production (NIH/PubMed).
Inhibition of viral RNA synthesis through nucleoside analog-mediated chain termination and siRNA-mediated degradation of viral mRNA.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA-directed RNA polymerase L (Zaire ebolavirus) (L protein).